WY-50295 is an orally active and selective 5-lipoxygenase inhibitor. In rat whole blood leukocytes, WY-50295 inhibits LTB4 formation with an IC50 of 40 µM and an oral ED50 of 18 mg/kg. WY-50295 is applicable for research into asthma and other leukotriene-dependent conditions.
Molecular Weight:
357.4
CAS Number:
[123016-21-7]
Formula:
C23H19NO3
Target:
Lipoxygenase
* VAT and and shipping costs not included. Errors and price changes excepted